Skip to main content Accessibility help
×
Home

The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia

  • Terry E. Goldberg (a1), Richard D. Greenberg (a2), Suzanne J. Griffin (a2), James M. Gold (a1), Joel E. Kleinman (a1), David Pickar (a3), S. Charles Schulz (a4) and Daniel R. Weinberger (a1)...

Abstract

Psychiatric symptoms and cognition were assessed in 13 patients with schizophrenia, one patient with schizoaffective disorder, and one patient with psychosis not otherwise specified while they received a conventional neuroleptic and again after an average of 15 months on clozapine. Despite improvements in psychiatric symptoms, attention, memory, and higher-level problem-solving were essentially unchanged. This suggests that certain cognitive deficits are relatively independent of psychotic symptoms in schizophrenia, and are probably central and enduring features of the disorder. Cognitive disability appeared to have been rate-limiting in the sample's rehabilitation, as patients' social and vocational adjustment remained marginal during the study. We also observed that treatment with clozapine was associated with a decline in some memory functions; the potent anticholinergic properties of the drug may have been responsible for this.

Copyright

Corresponding author

Clinical Brain Disorders Branch, Intramural Research Program, NIMH Neurosciences Center at St Elizabeths, Washington, DC 20032, USA

References

Hide All
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.
Benton, A. L., Hamsher, K. deS., Varney, N. R., et al (1978a) Facial Recognition. New York: Oxford University Press.
Benton, A. L., Hamsher, K. deS., Varney, N. R., et al (1978b) Judgment of Line Orientation. New York: Oxford University Press.
Bornstein, R. A. & Yang, V. (1991) Neuropsychological performance in medicated and unmedicated patients with Tourette's disorder. American Journal of Psychiatry, 148, 468471.
Brier, A., Schreiber, J. L., Dyer, J., et al (1991) NIMH longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry; 48, 239246.
Cassens, G., Inglis, A. K., Appelbaum, P. S., et al (1990) Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477499.
Claghorn, J., Honigfeld, G., Abuzzahab, F. S., et al (1987) The risks and benefits of clozapine versus chlorpromazine. Journal of Clinical Psychopharmacology, 7, 377384.
Classen, W. & Laux, G. (1988) Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry, 21, 295297.
Cleghorn, J. M., Kaplan, R. D., Szechtman, B., et al (1990) Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211219.
Coyle, J. T., Price, D. L. & DeLong, M. R. (1983) Alzheimer's disease: a disorder of central cholinergic innervation. Science, 219, 11841190.
DeFeillips, N. A. & McCampbell, E. (1979) The Booklet Category Test. Odessa: Psychological Assessment Resources.
Drachmas, D. A. & Leavitt, J. (1974) Human memory and the cholinergic system. Archives of Neurology, 30, 113121.
Farde, L., Wiesel, A. L., Nordstrom, G., et al (1989) D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology, 99 (suppl.), S28.
Gold, J. M. & Hurt, S. W. (1990) The effects of haloperidol on thought disorder and IQ in schizophrenia. Journal of Personality Assessment, 54, 390400.
Goldberg, T. E., Weinberger, D. R., Pliskin, N. H., et al (1987) Further evidence for dementia of the prefrontal-type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Archives of General Psychiatry, 44, 10661072.
Goldberg, T. E., Ragland, J. D., Torrey, E. F., et al (1990) Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry, 47, 10661072.
Goldberg, T. E., Torrey, E. F., Gold, J. M., et al (1993) Learning and memory in monozygotic twins discordant for schizophrenia. Psychological Medicine (in press).
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology, US Department of Health and Human Services Publication (ADM) 76–338, pp. 534535. Rockville, MD: US Government Printing Office.
Heaton, R. K. (1981) The Wisconsin Card Sorting Test Manual. Odessa: Psychological Assessment Resources.
Heaton, R. K. & Crowley, T. J. (1981) Effects of psychiatric disorders and their somatic treatments on neuropsychological test results. In Handbook of Clinical Neuropsychology (eds Filskov, D. & Boll, T. J.), pp. 481525. New York: Wiley.
Hollingshead, A. B. & Redlich, F. C. (1958) Social Class and Mental Illness. New York: Wiley.
Jastak, S. & Wilkinson, G. S. (1985) WRAT-R2 . Wilmington: Jastak Associates.
Kane, J., Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789796.
Kay, S. R. & Lindenmayer, J.-P. (1991) Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatment. Comprehensive Psychiatry, 32, 2835.
King, D. J. (1990) The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799811.
Kolb, B. & Whishaw, I. Q. (1983) Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients. Journal of Nervous and Mental Disease, 171, 435443.
Lalonde, F. (1985) Psychometric characteristics of a short form of the Category Test. Journal of Clinical and Experimental Neuropsychology, 6, 270.
Lezak, M. D. (1976) Neuropsychological Assessment. New York: Oxford University Press.
Louis, T. A., Lavori, P. W., Bailar, J. C., et al (1984) Crossover and self-controlled designs in clinical research. New England Journal of Medicine, 310, 2431.
Medalia, A., Gold, J. M. & Merriam, A. (1988) The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3, 249271.
Meltzer, H. Y. (1989) Clinical studies in the mechanism of action of clozapine: the dopamine–serotonin hypothesis of schizophrenia. Psychopharmacology, 99 (suppl.), 18.
Meltzer, H. Y., Bastani, B., Kwon, K. Y., et al (1989) A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology, 99 (suppl.), 68.
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799812.
Perlick, D., Stastny, P., Katz, I., et al (1986) Memory deficits and anticholinergic levels in chronic schizophrenia. American Journal of Psychiatry, 143, 230232.
Povlsen, V. J., Noring, U., Fog, R., et al (1985) Tolerability and therapeutic effect of clozapine. Acta Psychiatrica Scandinavica, 71, 176185.
Reitan, R. M. (1979) Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tucson: Ralph M. Reitan.
Richelson, E. (1980) Neuroleptics and neurotransmitter receptors. Psychiatric Annals, 10, 2126.
Richelson, E. (1984) Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. Journal of Clinical Psychiatry, 45, 331336.
Saletu, B., Grunberger, J., Kinzmayer, L., et al (1987) Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Pharmacopsychiatry, 20, 1227.
Silverstein, A. B. (1985) Two and four subtest short forms of the WAIS–R: a close look at validity and reliability. Journal of Clinical Psychology, 41, 9597.
Snyder, S., Greenberg, D. & Yamamura, H. I. (1974) Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects. Archives of General Psychiatry, 31, 5861.
Snyder, S. & Yamamura, H. I. (1977) Antidepressants and the muscarinic acetylcholine receptor. Archives of General Psychiatry, 34, 236239.
Spitzer, R. L., Williams, J. B. W., Gibbon, M., et al (1990) SCID. Washington, DC: American Psychiatric Press.
Spohn, H. E. & Strauss, M. E. (1989) Relation of neuroleptic and anticholinergic medications to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 98, 367380.
Taylor, M. A. & Abrams, R. (1984) Cognitive dysfunction in schizophrenia. American Journal of Psychiatry, 141, 186201.
Torrey, E. F. (1988) Surviving Schizophrenia: A Family Manual. New York: Harper & Row.
Tune, L. E., Strauss, M. E., Lew, M. F., et al (1982) Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. American Journal of Psychiatry, 139, 14601462.
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., et al (1991) Cloning of the gene for a human dopamine D4 receptor with higher affinity for the antipsychotic clozapine. Nature, 350, 610611.
Wechsler, D. (1981) WAIS–R. New York: Psychological Corporation.
Wechsler, D. & Stone, L. P. (1985) The Wechsler Memory Scale. New York: Psychological Corporation.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia

  • Terry E. Goldberg (a1), Richard D. Greenberg (a2), Suzanne J. Griffin (a2), James M. Gold (a1), Joel E. Kleinman (a1), David Pickar (a3), S. Charles Schulz (a4) and Daniel R. Weinberger (a1)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *